期刊文献+

用小鼠模型分析可溶性表达结核分枝杆菌Ag85A的免疫原性 被引量:5

Expression and immunogenicity of Ag85A protein of Mycobacterium tuberculosis
原文传递
导出
摘要 【目的】可溶性表达结核分枝杆菌Ag85A蛋白,并评价其免疫原性。【方法】利用冷休克表达质粒和含有伴侣质粒的大肠杆菌对Ag85A蛋白进行可溶性原核表达,并进行纯化与鉴定,通过C57BL/6小鼠模型对Ag85A蛋白的免疫原性,包括诱导机体特异性体液免疫应答和细胞免疫应答水平进行分析。【结果】重组菌诱导后裂解上清中检测到可溶性Ag85A蛋白的表达,经过亲和层析纯化收获了纯度在90%以上的Ag85A蛋白,Western blot鉴定显示其具有较好的免疫反应性。Ag85A蛋白免疫小鼠后,血清中可以检测到高水平的Ig G抗体效价,其中Ig G2b水平要高于Ig G1。通过特异性多肽、蛋白刺激脾脏和腹股沟淋巴结细胞可分泌高水平的IFN-γ、TNF-α等Th1型细胞因子。【结论】实现了Ag85A蛋白的可溶性表达,免疫特性评价显示Ag85A蛋白可诱导机体产生强烈的特异性体液免疫应答及Th1型的细胞免疫应答,从而为其进一步免疫学功能的研究奠定了重要基础。 [Objective] The aim of this study was to express Mycobacterium tuberculosis Ag85 A protein and to evaluate its immunogenicity in mice. [Methods] The cold expressed system and chaperone competent cells BL21 were combined to express Mycobacterium tuberculosis Ag85 A protein, then the protein was purified with affinity chromatography and identified by Western Blot analysis. [Results] The immunogenicity of the purified Ag85 A protein was evaluated in C57BL/6 mice. Results show that high level of specific Ig G was elicited in the serum, and the splenocytes and lymph node cells of immunized mice could produce more Th1 cytokines, such as IFN-γ and TNF-α,after stimulated with specific antigen. [Conclusions] Ag85 A protein can induce strong specific humoral and Th1 type cellular immune responses, providing an important biological material for further research and application.
出处 《微生物学报》 CAS CSCD 北大核心 2016年第5期804-813,共10页 Acta Microbiologica Sinica
基金 国家"973计划"(2012CB518805) 江苏省重点研发计划(BE2015343) 扬州市自然科学基金(YZ2014027) 国家自然科学基金(31201882) 江苏高校优势学科建设工程资助项目~~
关键词 结核分枝杆菌 AG85A 可溶性表达 免疫原性 Mycobacterium tuberculosis Ag85A soluble expression immunogenicity
作者简介 陈祥,chenxiang@yzu.edu.cn 通信作者。Tel:+86.514.87971136;E-mail:焦新安,jiao@yzu.edu.cn;
  • 相关文献

参考文献19

  • 1Wiker HG, Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiological Reviews, 1992, 56(4): 648-661.
  • 2Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan P J, Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science, 1997, 276(5317): 1420-1422.
  • 3D'Souza S, Rosseels V, Romano M, Tanghe A, Denis O, Jurion F, Castiglione N, Vanonckelen A, Palfliet K, Huygen K. Mapping of murine Thl helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacteriumtuberculosis. Infection and Immunity, 2003, 71 (1): 483-493.
  • 4Miki K, Nagata T, Tanaka T, Kim YH, Uchijima M, Ohara N, Nakamura S, Okada M, Koide Y. Induction of protective cellular immunity against Myeobacterium tuberculosis by recombinant attenuated self-destructing Listeria monoeytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51. Infection and Immunity, 2004, 72(4): 2014-2021.
  • 5Tarrant JP, Walsh M J, Blanchard MC, Lee TDG, Hoskin DW, Giacomantonio CA. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A. International Journal of Oncology, 2004, 25(6): 1693-1699.
  • 6Smaill F, Jeyanathan M, Smieja M, Medina MF, Thanthrige- Don N, Zganiacz A, Yin C, Heriazon A, Damjanovic D, Puri L, Hamid J, Xie F, Foley R, Bramson J, Gauldie J, Xing Z. A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti- adenovirus immunity. Science Translational Medicine, 2013, 5(205): 205ra134.
  • 7Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, Shea JE, McClain JB, Hussey GD, Hanekom WA, Mahomed H, McShane H. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. The Lancet, 2013, 381(9871): 1021-1028.
  • 8姜燕,Azuma Kalu,吕昌龙,单风平.结核分枝杆菌Ag85A DNA的克隆与原核表达[J].微生物学杂志,2007,27(3):16-20. 被引量:3
  • 9邓毛子,石春薇,王芳,付瑞玲,王春,方正明,范雄林.结核分枝杆菌Ag85A蛋白的原核表达、纯化和免疫反应性[J].基础医学与临床,2010,30(2):117-121. 被引量:5
  • 10张群,朱琳,楼觉人.重组结核杆菌Ag85a-ESAT6融合蛋白的原核表达、纯化及其生物活性[J].中国生物制品学杂志,2010,23(11):1153-1157. 被引量:4

二级参考文献35

共引文献24

同被引文献49

  • 1张倩,朱晓彬,李晓宁,肖潇.GeneXpert MTB/RIF技术检测结核分枝杆菌的应用评价[J].武汉大学学报(医学版),2019,40(6):932-935. 被引量:9
  • 2STEAD W.The origin and erratic global spread of tuberculosis:how the past explains the present and is the key to the future [J].Clin Chest Med,1997,18(1):65-77.
  • 3ANDERSEN P,DOHERTY T M.The success and failure of BCG-implications for a novel tuberculosis vaccine [J].Nat Rev Microbiol,2005,3:656-662.
  • 4MACIAG A,DAINESE E,RODRIGUEZ G M,et al.Global analysis of the Mycobacterium tuberculosis Zur (FurB) regulon [J].J Bacteriol,2007,189(3):730-740.
  • 5HERVAS S S,MAJLESSI L,SIMSOVA M,et al.High frequency of CD4+ T cells specific for the TB10.4 pro-tein correlates with protection against Mycobacterium tuberculosis infection [J].Infect Immun,2006,74(6):3396-3407.
  • 6STEFAN H E,KAUFMANN G H,PAUL-HENRI L.New vaccines for tuberculosis [J].Lancet,2010,375(9731):2110-2119.
  • 7DE JONGE M I,PEHAU A G,FRETZ M M,et al.ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity [J].J Bacteriol,2007,189(16):6028-6034.
  • 8BEKMURZAYEVA A,SYPABEKOVA M,KANAYEVA D.Tuberculosis diagnosis using immunodominant,secreted antigens of Mycobacterium tuberculosis [J].Tuberculosis (Edinb),2013,93(4):381-388.
  • 9HERVAS S S,MAJLESS L,SIMSOVA M,et al.High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection [J].Infect Immun,2006,74(6):3396-3407.
  • 10SKJOT R L,OETTINGER T,ROSENKRANDS I,et al.Comparative evaluation of low-molecular'mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens [J],Infect Immun,2000,68(1):214-220.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部